JPWO2020166557A1 - 妊娠高血圧腎症の治療方法 - Google Patents

妊娠高血圧腎症の治療方法 Download PDF

Info

Publication number
JPWO2020166557A1
JPWO2020166557A1 JP2020572244A JP2020572244A JPWO2020166557A1 JP WO2020166557 A1 JPWO2020166557 A1 JP WO2020166557A1 JP 2020572244 A JP2020572244 A JP 2020572244A JP 2020572244 A JP2020572244 A JP 2020572244A JP WO2020166557 A1 JPWO2020166557 A1 JP WO2020166557A1
Authority
JP
Japan
Prior art keywords
antithrombin
preeclampsia
mmhg
administration
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020572244A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020166557A5 (https=
Inventor
嘉秀 中村
高史 村山
謙一 高木
竜太郎 島崎
祐一 遠藤
洋紀 神田
佳代子 本山
雅也 加藤
隼一郎 折原
朋子 田中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Co Ltd
Original Assignee
Kyowa Kirin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Kirin Co Ltd filed Critical Kyowa Kirin Co Ltd
Publication of JPWO2020166557A1 publication Critical patent/JPWO2020166557A1/ja
Publication of JPWO2020166557A5 publication Critical patent/JPWO2020166557A5/ja
Priority to JP2023029934A priority Critical patent/JP2023060011A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2020572244A 2019-02-11 2020-02-10 妊娠高血圧腎症の治療方法 Pending JPWO2020166557A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023029934A JP2023060011A (ja) 2019-02-11 2023-02-28 妊娠高血圧腎症の治療方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962803888P 2019-02-11 2019-02-11
US62/803,888 2019-02-11
US201962820459P 2019-03-19 2019-03-19
US62/820,459 2019-03-19
PCT/JP2020/005130 WO2020166557A1 (ja) 2019-02-11 2020-02-10 妊娠高血圧腎症の治療方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023029934A Division JP2023060011A (ja) 2019-02-11 2023-02-28 妊娠高血圧腎症の治療方法

Publications (2)

Publication Number Publication Date
JPWO2020166557A1 true JPWO2020166557A1 (ja) 2021-12-16
JPWO2020166557A5 JPWO2020166557A5 (https=) 2022-10-25

Family

ID=72044881

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020572244A Pending JPWO2020166557A1 (ja) 2019-02-11 2020-02-10 妊娠高血圧腎症の治療方法
JP2023029934A Pending JP2023060011A (ja) 2019-02-11 2023-02-28 妊娠高血圧腎症の治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023029934A Pending JP2023060011A (ja) 2019-02-11 2023-02-28 妊娠高血圧腎症の治療方法

Country Status (7)

Country Link
US (1) US20220202920A1 (https=)
EP (1) EP3925616A4 (https=)
JP (2) JPWO2020166557A1 (https=)
AU (1) AU2020222120A1 (https=)
CA (1) CA3129755A1 (https=)
TW (1) TW202045203A (https=)
WO (1) WO2020166557A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021112606A1 (ko) 2019-12-05 2021-06-10 주식회사 엘지에너지솔루션 리튬 이차전지용 양극 활물질, 상기 양극 활물질의 제조 방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07316072A (ja) * 1994-05-24 1995-12-05 Green Cross Corp:The 妊娠中毒症治療剤
WO2016159204A1 (ja) * 2015-03-31 2016-10-06 協和発酵キリン株式会社 アンチトロンビン ガンマを含む治療用組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1890262B (zh) 2003-10-09 2015-01-28 协和发酵麒麟株式会社 抗凝血酶ⅲ组合物的制造方法
WO2008120801A1 (ja) 2007-04-02 2008-10-09 Kyowa Hakko Kirin Co., Ltd. アンチトロンビン組成物の製造方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07316072A (ja) * 1994-05-24 1995-12-05 Green Cross Corp:The 妊娠中毒症治療剤
WO2016159204A1 (ja) * 2015-03-31 2016-10-06 協和発酵キリン株式会社 アンチトロンビン ガンマを含む治療用組成物

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
MAKI M.ET AL.: "Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-control", THROMB HAEMOST., vol. 84, JPN6020008298, 2000, pages 583 - 90, XP055212802, ISSN: 0005038995 *
寺尾 俊彦: "血液凝固のインヒビター製剤, アンチトロンビンIII製剤−産婦人科", BIOMEDICAL PERSPECTIVES, vol. 8(1), JPN6020008299, 1999, pages 68 - 78, ISSN: 0005038996 *
日本内科学会雑誌, vol. 102(12), JPN6022046401, 2013, pages 3147 - 3153, ISSN: 0005038998 *
日水製薬株式会社, 「エバテストＡＴＩＩＩ」の添付文書, JPN6022046403, January 2018 (2018-01-01), pages 1 - 2, ISSN: 0005038999 *
鈴木 洋通: "妊娠高血圧症候群", 日本内科学会雑誌, vol. 104(2), JPN6020008300, 2015, pages 247 - 252, ISSN: 0005038997 *

Also Published As

Publication number Publication date
EP3925616A4 (en) 2022-12-21
TW202045203A (zh) 2020-12-16
AU2020222120A1 (en) 2021-09-02
EP3925616A1 (en) 2021-12-22
JP2023060011A (ja) 2023-04-27
WO2020166557A1 (ja) 2020-08-20
CA3129755A1 (en) 2020-08-20
US20220202920A1 (en) 2022-06-30

Similar Documents

Publication Publication Date Title
EP3370760B1 (en) Plasminogen replacement therapy for plasminogen-deficiency
KR20140135219A (ko) 자간전증의 치료에서의 안티트롬빈의 용도
JP2017501154A (ja) 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
Poon Ibuprofen lysine (NeoProfen) for the treatment of patent ductus arteriosus
JP2023060011A (ja) 妊娠高血圧腎症の治療方法
Heistinger et al. Cerebral sinus thrombosis in a patient with hereditary protein S deficiency: case report and review of the literature
JPH06510769A (ja) 低血圧症と関連疾患の治療のためのアミノ酸非経口製剤
CA2492858C (en) Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients
Benz et al. Clinical manifestations and diagnosis of the thalassemias
CN1688337B (zh) 用于调节先兆子痫患者和子痫患者的钠/钾三磷酸腺苷酶活性的地高辛免疫fab的用途
US20210260007A1 (en) Compositions, methods, and compounds for bowel disease treatment via increased prostacyclin release
US20200147188A1 (en) Therapeutic composition containing antithrombin gamma
KR20210126515A (ko) 니클로사마이드를 포함하는 폐고혈압의 예방 및 치료용 조성물
US20070254837A1 (en) Treatment for Necrotizing Enterocolitis
DK2961422T3 (en) Therapeutic agent for amniotic fluid embolism
CN113289019B (zh) 血管紧张素ⅱ1型受体拮抗剂的用途
US20210346461A1 (en) Utilization of endogenous oubain-regulating compounds and compositions thereof in treatment of vascular disease
Shanmugam et al. Endocrine-related Abnormalities in Locally Advanced Head and Neck Cancer Surgery Patients after Chemoradiation: A Myth or Mystery
Delpón Juan Tamargo, Ricardo Caballero, and
Beard et al. Haemoglobinopathies in immigrant families
CN113301907A (zh) 用于治疗和/或改善伴有凝血障碍的败血症的药物
HK40059596A (en) Drug for treating and/or improving septicemia associated with coagulation abnormality
Evans Tumour necrosis factor as a mediator of endotoxaemia
JP2014162789A (ja) 羊水塞栓症治療剤
JP2000505819A (ja) 製剤製品

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221017

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221017

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20221017

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221101

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221216

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230418